Quiz β Retinal Arterial Macroaneurysm (RAM)
Q1 β Recall
What order of retinal arteriolar branch is most commonly affected in RAM, and what is the most common location?
Hint: Think about the major arcade vessels and which quadrant is most frequently involved.
Answer: 2nd-order retinal arterioles are most commonly affected. The most common location is along the superotemporal arcade. More specifically, RAMs are usually found within a third-degree branch of one of the four main arcade arteries, but the superotemporal is by far the most frequent. See retinal-arterial-macroaneurysm.
Q2 β Recall
What size range (in ΞΌm) defines a retinal arterial macroaneurysm?
Hint: Itβs a fairly narrow range β think about what separates a macroaneurysm from normal arteriolar caliber on one end and from a tumor-like lesion on the other.
Answer: 100β250 ΞΌm in diameter. This distinguishes RAM from microaneurysms (which are smaller, capillary-level) and from larger vascular malformations. See retinal-arterial-macroaneurysm.
Q3 β Pathophysiology
Describe the histopathological findings in RAM as reported by Fichte et al. What systemic vascular process do these changes resemble?
Hint: Think about what youβd see in an aging blood vessel wall anywhere in the body β the cellular infiltrate and structural protein changes.
Answer: Fichte et al. (1978) found vessel wall thickening, deposition of fibrin, and infiltration by foamy macrophages. These changes closely resemble age-related arteriosclerotic changes seen in systemic vessels throughout the body. The mechanism is focal embolic damage β localized ischemia β increased intimal collagen remodeling β increased vessel permeability β dilation. See retinal-arterial-macroaneurysm, hypertensive-retinopathy.
Q4 β Clinical Reasoning
A 72-year-old hypertensive woman presents with sudden painless vision loss in one eye. Fundoscopy reveals simultaneous preretinal, intraretinal, and subretinal hemorrhage along the superotemporal arcade. What is the most likely diagnosis, and what are the only two other common conditions that produce this multilevel hemorrhage pattern?
Hint: The demographics (elderly, female, hypertensive) + location (superotemporal) + the specific hemorrhage pattern are the giveaway. For the differentials, think about blood dyscrasias and non-accidental injury.
Answer: Most likely diagnosis is ruptured hemorrhagic retinal arterial macroaneurysm (RAM). The classic triad of elderly + female + hypertensive with superotemporal multilevel hemorrhage is virtually pathognomonic. The only two other common causes of simultaneous preretinal + intraretinal + subretinal hemorrhage are: (1) anemic/leukemic retinopathy and (2) shaken baby syndrome (abusive head trauma). This multilevel hemorrhage pattern is a high-yield exam point. See retinal-arterial-macroaneurysm, vitreous-hemorrhage.
Q5 β Epidemiology
What percentage of RAM patients have concurrent hypertension? What is the reported incidence of RAM per the Beijing Eye Study?
Hint: The hypertension figure is strikingly high β think three quarters. The incidence denominator is in the thousands per eye.
Answer: 75% of RAM patients have concurrent hypertension β making it the single strongest systemic association. The Beijing Eye Study (Xu et al., 2007) reported an incidence of approximately 1 per 9,000 eyes. Additionally, 10% of hemorrhagic RAM cases are bilateral. The condition predominantly affects elderly women. See retinal-arterial-macroaneurysm, hypertensive-retinopathy.
Q6 β Classification & Prognosis
RAM is classified into two types. Name them and explain which carries the better visual prognosis β and why this might be considered counterintuitive.
Hint: One type bleeds, the other leaks. Youβd expect the bleeder to be worse, but think about what chronic leakage does to the macula.
Answer: RAM is classified as hemorrhagic or exudative. Counterintuitively, the hemorrhagic type has the better visual prognosis. This is surprising because hemorrhage sounds more dramatic, but hemorrhagic RAMs tend to thrombose and self-seal after rupture, leading to spontaneous resolution. Exudative RAMs, on the other hand, cause persistent macular edema and hard exudate deposition that chronically damages the fovea. The worst prognosis overall is seen with persistent macular edema or subretinal hemorrhage. See retinal-arterial-macroaneurysm.
Q7 β Imaging: FFA
On fluorescein angiography, how does the filling pattern differ between saccular and fusiform macroaneurysms? What additional FFA finding is typically seen in both types?
Hint: Think about the morphology β a sac-like outpouching fills differently from a spindle-shaped dilation thatβs still in-line with flow. One fills early, the other late.
Answer: On FFA:
- Fusiform (spindle-shaped) RAM: fills in the early arterial phase β dye flows through the dilated segment as part of normal arterial transit
- Saccular (sac-like) RAM: fills in the mid-to-late phase β dye pools into the outpouching more slowly
Both types show vessel wall staining, and late leakage may be present (especially in exudative type). FFA is particularly valuable when hemorrhage obscures the aneurysm on fundoscopy. See fluorescein-angiography, retinal-arterial-macroaneurysm.
Q8 β Management
A patient with exudative RAM has progressive macular edema threatening the fovea. You consider laser photocoagulation. Describe the laser parameters used, and state the major complication risk and its reported incidence.
Hint: The laser is applied adjacent to (not on) the aneurysm. Think large spots, moderate power, a few rows. The feared complication involves the arterial supply downstream.
Answer: Laser parameters: moderate-intensity, large-spot size (200β500 ΞΌm), 2β3 rows applied immediately adjacent to the macroaneurysm (not directly on it). The major complication is branch retinal artery occlusion (BRAO), reported in up to 16% of cases. This is why laser for RAM remains controversial β some studies also show significant decrease in visual acuity post-laser. Laser is reserved only for vision-threatening exudation when observation is not tenable. See laser-photocoagulation, retinal-arterial-macroaneurysm.
Q9 β Management: Hemorrhage
Differentiate the management approach for submacular hemorrhage vs premacular (subhyaloid) hemorrhage in the setting of a ruptured RAM. Why is urgent treatment of submacular hemorrhage important?
Hint: One uses gas + a clot-busting agent, the other uses a laser to drain. Think about where the blood is sitting relative to the retina and why that matters for photoreceptors.
Answer:
- Submacular hemorrhage: Treat with pneumatic displacement β intravitreal gas injection (SF6 or C3F8) Β± tissue plasminogen activator (tPA) to lyse the clot. Patient is positioned face-down so the gas bubble pushes blood inferiorly away from the fovea. Urgency is critical because subretinal blood is directly toxic to the retina and ellipsoid zone β iron from hemoglobin, fibrin contraction, and physical barrier to RPE-photoreceptor metabolite exchange all cause irreversible photoreceptor damage.
- Premacular (subhyaloid) hemorrhage: Treat with Nd:YAG posterior hyaloidotomy β laser creates an opening in the posterior hyaloid face at the inferior edge of the hemorrhage, releasing the trapped blood into the vitreous cavity where it disperses and clears faster.
See pneumatic-displacement, yag-posterior-hyaloidotomy, retinal-arterial-macroaneurysm.
Q10 β Pharmacotherapy
What evidence exists for anti-VEGF use in RAM? Cite the key study, the agents used, the number of eyes, and the outcome.
Hint: The landmark case series is from 2013. Think Italian group, Am J Ophthalmol, and a fairly impressive number of eyes for a rare condition.
Answer: The key study is Pichi et al. (2013) published in the American Journal of Ophthalmology. They evaluated intravitreal bevacizumab for macular complications from RAM in a case series of 38 eyes. The outcome showed reduction in macular edema and hard exudates in all 38 eyes. Ranibizumab has also been used (Tsakpinis et al., 2011 β single case report, 39-month follow-up with bevacizumab for multilevel hemorrhage). However, anti-VEGF for RAM has not been extensively studied and there are no RCTs or approved guidelines. See bevacizumab, ranibizumab, intravitreal-injections, retinal-arterial-macroaneurysm.
Q11 β Differential Diagnosis
Name two conditions that can mimic RAM on fundoscopy and four conditions that can cause secondary macroaneurysm formation.
Hint: Mimics = other vascular retinal lesions with dilation/exudation. Secondary causes = conditions that damage retinal vessel walls.
Answer: Mimics (similar fundoscopic appearance):
- Coats disease β retinal telangiectasia with exudation (but: young males, not elderly females)
- Von Hippel-Lindau disease β retinal capillary hemangioblastoma (but: feeder vessels, younger age, systemic associations)
Secondary causes (conditions that produce secondary RAM):
- Branch retinal vein occlusion (BRVO)
- Diabetic retinopathy
- Radiation retinopathy
- Retinal arteritis
When any of these underlie the macroaneurysm, the primary cause should be identified and treated. See coats-disease, von-hippel-lindau, branch-retinal-vein-occlusion, diabetic-retinopathy, radiation-retinopathy.
Q12 β Gap-Probing: Clinical Decision-Making
A 68-year-old man is found to have an incidental, asymptomatic RAM on routine dilated exam with no macular involvement. What is your management plan, and what single systemic investigation is mandatory? If this patient returns 6 months later with new exudative macular edema from the same RAM, would you choose laser or anti-VEGF as your first intervention β and why?
Hint: First visit is straightforward β most RAMs do well on their own. The second visit forces you to weigh the evidence: laser has guidelines-level tradition but a scary complication rate; anti-VEGF has promising data but limited evidence.
Answer: First visit (incidental, asymptomatic RAM):
- Observation β most RAMs regress spontaneously with good visual outcome
- Mandatory systemic investigation: blood pressure measurement / hypertension workup (present in 75% of cases; control of HTN is the primary prevention strategy)
- Schedule regular follow-up to monitor for progression
Second visit (new exudative macular edema): This is where clinical judgment comes in β and the evidence is genuinely mixed:
- Laser photocoagulation is the traditional approach (moderate-intensity, 200β500 ΞΌm, adjacent to aneurysm), but carries a 16% risk of BRAO and some studies show post-laser VA decline
- Anti-VEGF (bevacizumab) showed reduction in macular edema and hard exudates in all 38 eyes in the Pichi et al. series, with a better safety profile
A reasonable argument for anti-VEGF first: lower complication risk, good efficacy data (though limited), and laser can be reserved as second-line if anti-VEGF fails. However, this is a clinical judgment call β there are no approved guidelines, and some surgeons still prefer direct laser for well-defined exudative RAM. The key is that this patient needs intervention because persistent macular edema carries the worst prognosis of any RAM presentation.
See retinal-arterial-macroaneurysm, laser-photocoagulation, bevacizumab, hypertensive-retinopathy.